Osaka Medical College Hospital

Takatsuki-shi, Osaka 569-8686

1 studies enrolling now · 6 studies all time

What they study most

Crohn's Disease, First Line Non-Small Cell Lung Cancer, Ulcerative Colitis

Studies at this site

• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis — Completed
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis — Completed
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis — Completed